HEALTH● LOW1h ago · Oct 9, 2026, 3:21 PM
Teva gains approval of monthly olanzapine injection for schizophrenia
Seeking Alpha Tech · global
Teva has received approval for a monthly olanzapine injection used to treat schizophrenia. This development offers a new treatment option for individuals suffering from the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH37m agoDid Russia play by the rules in reporting lab worker's death?NPR NewsHEALTH41m agoDoes each new covid-19 variant pose a significant threat?New ScientistHEALTH48m agoMaps and charts show record number of measles cases in U.S. this yearCBS NewsHEALTH59m agoSri Narayani Hospital completes 125 kidney transplants in Vellore, honours doctorsThe Hindu